Insider Transactions in Q1 2021 at Moelis & CO (MC)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 30
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
6,816
-1.42%
|
$381,696
$56.05 P/Share
|
Mar 29
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
3,500
-0.72%
|
$196,000
$56.0 P/Share
|
Mar 26
2021
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.49%
|
-
|
Mar 26
2021
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.94%
|
-
|
Mar 26
2021
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.95%
|
-
|
Mar 26
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
5,728
-1.17%
|
$320,768
$56.01 P/Share
|
Mar 26
2021
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.94%
|
-
|
Mar 26
2021
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.95%
|
-
|
Mar 26
2021
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.3%
|
-
|
Mar 26
2021
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.94%
|
-
|
Mar 26
2021
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.95%
|
-
|
Mar 24
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
541
-0.11%
|
$30,296
$56.18 P/Share
|
Mar 23
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
5,000
-1.01%
|
$280,000
$56.0 P/Share
|
Mar 22
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
4,754
-0.95%
|
$266,224
$56.1 P/Share
|
Mar 19
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
60,000
-10.71%
|
$3,360,000
$56.64 P/Share
|
Mar 18
2021
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
6,691
-100.0%
|
$388,078
$58.0 P/Share
|
Mar 18
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
60,000
-9.68%
|
$3,480,000
$58.13 P/Share
|
Mar 17
2021
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
6,692
-50.0%
|
$381,444
$57.0 P/Share
|
Mar 17
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
60,000
-8.82%
|
$3,420,000
$57.28 P/Share
|
Mar 16
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
60,000
-8.11%
|
$3,360,000
$56.28 P/Share
|
Mar 15
2021
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
6,692
-33.34%
|
$368,060
$55.5 P/Share
|
Mar 15
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
60,000
-7.5%
|
$3,300,000
$55.75 P/Share
|
Mar 01
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
43,613
-33.14%
|
$2,355,102
$54.5 P/Share
|
Feb 24
2021
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
17,020
-99.24%
|
$902,060
$53.08 P/Share
|
Feb 23
2021
|
Christopher Callesano Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,346
-100.0%
|
$67,300
$50.05 P/Share
|
Feb 23
2021
|
Christopher Callesano Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,295
-49.03%
|
$69,930
$54.29 P/Share
|
Feb 23
2021
|
Christopher Callesano Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,641
+50.0%
|
-
|
Feb 23
2021
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
17,027
-13.84%
|
$919,458
$54.29 P/Share
|
Feb 23
2021
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
37,112
+23.18%
|
-
|
Feb 23
2021
|
Elizabeth Crain |
SELL
Payment of exercise price or tax liability
|
Direct |
14,000
-41.09%
|
$756,000
$54.29 P/Share
|
Feb 23
2021
|
Elizabeth Crain |
BUY
Exercise of conversion of derivative security
|
Direct |
27,518
+44.68%
|
-
|
Feb 23
2021
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
75,090
-49.58%
|
$4,054,860
$54.29 P/Share
|
Feb 23
2021
|
Navid Mahmoodzadegan Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
151,446
+50.0%
|
-
|
Feb 23
2021
|
Jeffrey Raich Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
53,188
-49.58%
|
$2,872,152
$54.29 P/Share
|
Feb 23
2021
|
Jeffrey Raich Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
107,272
+50.0%
|
-
|
Feb 23
2021
|
Joseph Simon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,189
-100.0%
|
$699,017
$53.0 P/Share
|
Feb 23
2021
|
Joseph Simon Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,524
-46.63%
|
$622,296
$54.29 P/Share
|
Feb 23
2021
|
Joseph Simon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,713
+50.0%
|
-
|
Feb 23
2021
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
191
-1.1%
|
$10,314
$54.29 P/Share
|
Feb 23
2021
|
Osamu R. Watanabe General Counsel, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
17,211
+49.81%
|
-
|
Feb 23
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,410
-1.06%
|
$76,140
$54.29 P/Share
|
Feb 23
2021
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
128,524
+29.63%
|
-
|
Feb 23
2021
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
800,000
+50.0%
|
-
|
Feb 19
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
28,234
-86.24%
|
$1,524,636
$54.78 P/Share
|
Feb 18
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
72,064
-35.07%
|
$3,963,520
$55.03 P/Share
|
Feb 16
2021
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
61,987
-20.47%
|
$3,347,298
$54.93 P/Share
|
Feb 12
2021
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
2,116
-2.4%
|
$112,148
$53.99 P/Share
|
Feb 12
2021
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
4,609
+4.98%
|
-
|
Feb 12
2021
|
Kenneth Shropshire |
SELL
Open market or private sale
|
Direct |
1,645
-22.27%
|
$88,830
$54.69 P/Share
|